About vaccination, the latest news is coming!

On the 21st, the joint prevention and control mechanism of the State Council held a press conference to introduce the safety and effectiveness of vaccines in COVID-19. Look at the main points and sort out ↓

At present, low-risk areas in China hold a "green code" for healthy traffic, and they can travel in an orderly manner on the premise of normal temperature measurement and personal protection, and all localities are not allowed to overweight without authorization.

As of 24: 00 on March 20th, 74.956 million doses of Covid-19 vaccine were reported nationwide.

At present, the COVID-19 epidemic is still prevalent in the world, and no one can be immune to it. Vaccination is the most effective means to prevent and control the COVID-19 epidemic.

According to the existing production arrangements, the annual vaccine output can fully meet the vaccination needs of the whole country.

At present, COVID-19 vaccination has been started for the elderly over 60 who are in good physical condition. Vaccine research and development units are also accelerating the research and development process. After clinical trials have obtained sufficient safety and effectiveness data, large-scale vaccination will be carried out for the elderly over 60 years old.

At present, the four vaccines listed in China have been examined and approved by the competent government departments, which are safe and effective. Because the varieties of vaccines purchased in different provinces and cities may be different, everyone needs to be vaccinated as soon as possible according to the unified arrangements of the provinces and cities where they are located.

In China, people still need to wear masks indoors or in closed places where people gather, regardless of whether they are vaccinated or not.

For the time being, the entry vaccinators will not be exempted from testing and isolation measures.

Wang Huaqing, chief expert of immunization program of China CDC, said that at present, China CDC is still further understanding and verifying this case. Our country has approved the vaccines for conditional marketing or emergency use abroad. In the early phase III clinical trial, the protective effect is to protect most people from getting sick, and its effect of preventing severe diseases is more obvious. From the post-marketing evaluation results of the vaccines currently used abroad, after vaccination, there are still some individuals who fail to protect, and the reasons for the failure still need to be studied and investigated.

Source: CCTV News

Original title: "About vaccination, the latest news is coming! 》

Read the original text